血液・血液成分の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

血液・血液成分市場の世界需要は、2023年の179億6,000万米ドルから2032年には254億米ドル近くの市場規模に達すると推定され、調査期間2024-2032年のCAGRは3.93%です。

血液・血液成分とは、全血と赤血球、白血球、血小板、血漿などの分離した成分を指し、治療に使用されます。これらの成分は、貧血、血液凝固障害、外傷、外科手術の患者への輸血など、様々な治療目的に不可欠です。血液成分は、適合性と安全性を確保するために、レシピエントの血液型に注意深く適合されます。血液を成分に分離することで、的を絞った治療が可能になり、献血された血液の使用が最適化され、様々な臨床現場における患者の転帰が改善されます。

市場力学

外傷、外科手術、慢性疾患の増加により、患者の状態を効果的に管理するために血液・血液成分の使用が必要とされています。さらに、輸血を必要とする病状に罹患しやすい世界人口の高齢化が、市場を大きく押し上げています。採血、処理、保存技術の進歩は、血液・血液成分の安全性と効率を高め、需要をさらに促進しています。献血に対する意識の高まりや、自発的な献血を奨励する政府の取り組みも、市場を推進する大きな要因となっています。さらに、血液や血液成分の安全性を確保するための高度なスクリーニングや検査方法の開拓も、市場の成長に寄与しています。世界の病院、血液銀行、ヘルスケア施設の増加は、これらの重要な製品の入手可能性とアクセシビリティを拡大しています。しかし、輸血感染症のリスクや、血液処理と保存の高コストが、今後数年間の市場成長の課題となる可能性があります。

この調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、血液および血液成分の世界市場における各セグメントを包括的に評価することもできます。血液および血液成分産業の成長と動向は、この調査への全体的なアプローチを提供します。

市場セグメンテーション

血液および血液成分市場レポートのこのセクションでは、国および地域レベルのセグメントに関する詳細なデータを提供し、それによって戦略家がそれぞれの製品またはサービスのターゲット層を特定する上で、今後の機会を支援します。

製品別

• 全血
• 血液成分（赤血球、血小板、血漿、白血球）

用途別

• 貧血
• 外傷・手術
• がん治療
• 出血性疾患
• その他

用途別

• 病院
• 外来手術センター
• その他

地域分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカにおける血液および血液成分市場の現在および将来の需要を強調する地域展望を取り上げます。さらに、著名な全地域における個々の用途セグメントの需要・推定・予測にも焦点を当てています。

ご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

• 市場のハイライト
• 世界市場スナップショット

第3章 血液・血液成分- 産業分析

• イントロダクション：市場力学
• 市場促進要因
• 市場抑制要因
• 市場機会
• 業界動向
• ポーターのファイブフォース分析
• 市場の魅力分析

第4章 バリューチェーン分析

• バリューチェーン分析
• 原材料分析
  • 原材料リスト
  • 原材料メーカーリスト
  • 主要原材料の価格動向
• 潜在的バイヤーのリスト
• マーケティングチャネル
  • ダイレクトマーケティング
  • インダイレクトマーケティング
  • マーケティングチャネル発展動向

第5章 血液・血液成分の世界市場分析：製品別

• 製品別概要
• 製品別の過去および予測データ分析
• 全血
• 血液成分（赤血球、血小板、血漿、白血球）

第6章 血液・血液成分の世界市場分析：用途別

• 概要：用途別
• 過去および予測データ分析：用途別
• 貧血
• 外傷・手術
• がん治療
• 出血性疾患
• その他

第7章 血液および血液成分の世界市場分析：最終用途別

• 最終用途別概要
• 最終用途別の過去および予測データ分析
• 病院
• 外来手術センター
• その他

第8章 血液・血液成分の世界市場分析：地域別

• 地域別展望
• イントロダクション
• 北米売上分析
  • 概要、実績と予測
  • 北米：セグメント別
  • 北米国別
  • 米国
  • カナダ
  • メキシコ
• 欧州売上分析
  • 概要、実績と予測
  • 欧州セグメント別
  • 欧州国別
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • ロシア
  • その他欧州
• アジア太平洋売上分析
  • 概要、実績と予測
  • アジア太平洋セグメント別
  • アジア太平洋国別
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア
  • 東南アジア
  • その他アジア太平洋
• ラテンアメリカ売上分析
  • 概要、実績と予測
  • ラテンアメリカセグメント別
  • ラテンアメリカ国別
  • ブラジル
  • アルゼンチン
  • ペルー
  • チリ
  • その他ラテンアメリカ
• 中東・アフリカ売上分析
  • 概要、実績と予測
  • 中東・アフリカセグメント別
  • 中東・アフリカ国別一覧
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東・アフリカ

第9章 血液・血液成分企業の競合情勢

• 血液・血液成分市場の競合
• 提携・協力・協定
• 合併・買収
• 新製品発売
• その他の開発

第10章 企業プロファイル

• 上位企業の市場シェア分析
• 市場集中度
• European Blood Alliance
• Australian Red Cross
• Indian Red Cross
• American Association Of Blood Banks
• South African National Blood Service

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Product (USD MN)
• Whole Blood Market Sales By Geography (USD MN)
• Blood Components (Red blood cells, Platelets, Plasma, White Blood Cells) Market Sales By Geography (USD MN)
• Analysis By Application (USD MN)
• Anaemia Market Sales By Geography (USD MN)
• Trauma & Surgery Market Sales By Geography (USD MN)
• Cancer Treatment Market Sales By Geography (USD MN)
• Bleeding Disorders Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Analysis By End-Use (USD MN)
• Hospitals Market Sales By Geography (USD MN)
• Ambulatory Surgical Centers Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Blood and Blood Components Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Blood and Blood Components Report
• Market Research Process
• Market Research Methodology
• Global Blood and Blood Components Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Product
• Market Attractiveness Analysis By Application
• Market Attractiveness Analysis By End-Use
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Product (USD MN)
• Whole Blood Market Sales By Geography (USD MN)
• Blood Components (Red blood cells, Platelets, Plasma, White Blood Cells) Market Sales By Geography (USD MN)
• Global Market Analysis By Application (USD MN)
• Anaemia Market Sales By Geography (USD MN)
• Trauma & Surgery Market Sales By Geography (USD MN)
• Cancer Treatment Market Sales By Geography (USD MN)
• Bleeding Disorders Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Market Analysis By End-Use (USD MN)
• Hospitals Market Sales By Geography (USD MN)
• Ambulatory Surgical Centers Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

The global demand for Blood and Blood Components Market is presumed to reach the market size of nearly USD 25.4 Billion by 2032 from USD 17.96 Billion in 2023 with a CAGR of 3.93% under the study period 2024-2032.

Blood and blood components refer to whole blood and its separated components, such as red blood cells, white blood cells, platelets, and plasma, used in medical treatments. These components are critical for various therapeutic purposes, including transfusions for patients with anemia, clotting disorders, trauma, and surgical procedures. Blood components are carefully matched to the recipient's blood type to ensure compatibility and safety. The separation of blood into its components allows for targeted treatments, optimizing the use of donated blood and improving patient outcomes in various clinical settings.

MARKET DYNAMICS

The rising incidence of trauma cases, surgical procedures, and chronic diseases necessitates the use of blood and blood components to manage patients' conditions effectively. Additionally, the aging global population, more susceptible to medical conditions requiring blood transfusions, significantly boosts the market. Advancements in blood collection, processing, and storage technologies are enhancing the safety and efficiency of blood and blood components, further driving their demand. The increasing awareness about blood donation and government initiatives to encourage voluntary blood donation are also significant factors propelling the market. Furthermore, the development of advanced screening and testing methods to ensure the safety of blood and blood components contributes to market growth. The rise in the number of hospitals, blood banks, and healthcare facilities globally is expanding the availability and accessibility of these critical products. However, the risk of transfusion-transmitted infections and the high cost of blood processing and storage may challenge market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Blood and Blood Components. The growth and trends of Blood and Blood Components industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Blood and Blood Components market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Whole Blood
• Blood Components (Red blood cells, Platelets, Plasma, White Blood Cells)

By Application

• Anaemia
• Trauma & Surgery
• Cancer Treatment
• Bleeding Disorders
• Others

By End-Use

• Hospitals
• Ambulatory Surgical Centers
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Blood and Blood Components market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Blood and Blood Components market include European Blood Alliance, Australian Red Cross, Indian Red Cross, American Association Of Blood Banks, South African National Blood Service. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. BLOOD AND BLOOD COMPONENTS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-Use
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL BLOOD AND BLOOD COMPONENTS MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data Analysis By Product
• 5.3. Whole Blood Historic and Forecast Sales By Regions
• 5.4. Blood Components (Red blood cells, Platelets, Plasma, White Blood Cells) Historic and Forecast Sales By Regions

6. GLOBAL BLOOD AND BLOOD COMPONENTS MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data Analysis By Application
• 6.3. Anaemia Historic and Forecast Sales By Regions
• 6.4. Trauma & Surgery Historic and Forecast Sales By Regions
• 6.5. Cancer Treatment Historic and Forecast Sales By Regions
• 6.6. Bleeding Disorders Historic and Forecast Sales By Regions
• 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL BLOOD AND BLOOD COMPONENTS MARKET ANALYSIS BY END-USE

• 7.1. Overview By End-Use
• 7.2. Historical and Forecast Data Analysis By End-Use
• 7.3. Hospitals Historic and Forecast Sales By Regions
• 7.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
• 7.5. Others Historic and Forecast Sales By Regions

8. GLOBAL BLOOD AND BLOOD COMPONENTS MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE BLOOD AND BLOOD COMPONENTS COMPANIES

• 9.1. Blood and Blood Components Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF BLOOD AND BLOOD COMPONENTS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. European Blood Alliance
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. Australian Red Cross
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Indian Red Cross
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. American Association Of Blood Banks
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. South African National Blood Service
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies